• SENSEX 74,459.53
    308.49 (+0.42%)
  • BANKNIFTY 54,686.95
    -222.70 (--0.41%)
  • Jio Platforms
    1,438.95 1,490.00(%)
  • NSE
    1,775.20 1,640.25(%)
  • Dalmia BharatLtd
    1,320.00 1,320.00(%)
  • Anand Rathi Wea.
    2,246.45 1,354.00(%)
  • Reliance Industries
    1,152.50 1,152.30(%)
  • Ather Energy
    1,782.05 1,782.05(%)
  • Laurus Labs
    2,392.00 2,392.00(%)
  • Sagility
    41.79 35.82(%)
  • UltraTech Cem.
    11,005.00 10,329.00(%)
  • Tonbo Imaging
    1,330.00 1,343.80(%)
  • Indian Hotels Co
    824.00 824.00(%)
  • Trent
    3,059.00 3,399.75(%)
  • HDFC Bank
    695.50 1,017.90(%)
  • ICICI AMC
    2,688.00 2,528.90(%)
  • Hexaware Tech.
    497.95 400.35(%)
  • Suzlon Energy
    33.21 33.21(%)
  • Godrej Consumer
    777.65 777.65(%)
  • Diamond Power
    350.00 406.80(%)
  • Equitas Sma. Fin
    47.26 47.26(%)
  • APL Apollo Tubes
    2,161.00 1,691.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Adline Chem Lab Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5655.0
  • ISIN : INE276T01018
15.79 0 (0.00%)
  • As on 31 Oct 2026 (EOD)

  • Today’s Low

    15.79

  • Today’s High

    15.79

  • Open

    15.79

  • Perv Close

    15.79

  • 52W Low

    7.60

  • 52W High

    15.79

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    9.24

  • Div & Yield %

    0.00

  • Book Value(₹)

    -3.03

  • Debt-Equity Ratio

    0.00

  • AGM Date

    12-Oct-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    9.24

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.85

  • BV (₹)

    -3.00

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -0.28

  • NP Var(%)

    -112.0

  • Div%

    0.0

  • CPS (₹)

    -0.50

  • EPS (₹)

    -0.50

  • Traded Value (₹ in Lakhs)

    9.24

  • 52 Week High

    15.79

  • 52 Week Low

    7.60

  • Price BSE

    16.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    9.24

  • P/C Ratio

    -33.30

  • P/E Ratio

    -33.30

  • Price Vs.BV

    -0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.74 6.33
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.74 6.33
Other Income 0.01 0.25 0.00 1.00 1.33 0.00
Stock Adjustments 0.00 0.00 0.00 -0.26 -0.13 -0.70
Total Income 0.01 0.25 0.00 0.74 1.94 5.63
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.35 2.33
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.01 0.03
Employee Cost 0.02 0.18 0.04 0.05 0.18 1.71
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.10
Selling and Administration Expenses 0.15 0.11 0.13 0.07 0.23 1.08
Miscellaneous Expenses 0.04 0.00 0.01 4.76 0.12 0.60
Employee Benefit Expenses 0.02 0.18 0.04 0.05 0.18 1.71
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.20 0.29 0.18 4.88 0.90 5.86
Operating Profit -0.19 -0.05 -0.18 -4.15 1.03 -0.23
Interest 0.13 0.16 0.12 0.00 0.01 0.03
Gross Profit -0.32 -0.21 -0.30 -4.15 1.02 -0.26
Depreciation 0.00 0.00 0.00 0.09 0.35 1.02
Profit Before Tax -0.32 -0.21 -0.30 -4.24 0.67 -1.28
Current Tax 0.00 -0.10 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.04 0.03 -0.03 0.00 -0.05 0.00
Reported Net Profit -0.28 -0.13 -0.27 -4.23 0.72 -1.28
Extraordinary Items 0.00 0.00 0.00 -4.35 1.14 0.00
Adjusted Net Profit -0.28 -0.13 -0.27 0.12 -0.42 -1.28
Adjustment below Net Profit 0.00 0.01 0.00 0.00 0.00 0.00
P & L Balance brought forward -8.01 -7.89 -7.62 -3.38 -4.10 -2.82
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -8.29 -8.01 -7.89 -7.62 -3.38 -4.10
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.48 -0.23 -0.46 -7.24 1.23 -2.19
Earnings Per Share(Adj)-Unit Curr -0.48 -0.23 - -7.24 1.23 -2.19
Book Value -3.03 -2.55 -2.35 -2.68 4.53 3.30
Book Value(Adj)-Unit Curr -3.03 -2.55 - -2.68 4.53 3.30

Shareholding Pattern

  • Promoter Group

    25.85%

  • Public Share Holding

    74.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,512,440 25.85 1,512,440 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,512,440 25.85 1,512,440 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 28,510 0.49 8,800 14
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 575,850 9.84 9,450 946
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 900 0.02 900 6
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 483,900 8.27 41,400 9
Individuals holding nominal share capital up to Rs. 1 lakh 3,243,400 55.44 300,300 17,456
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,337,560 74.15 365,850 18,432
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,850,000 100.00 1,878,290 18,433

Company Background

Adline Chem Lab LtdPharmaceuticals - Indian - Formulations

  • Adline Chem Lab Ltd
  • BSE Code : 5655.0
  • ISIN : INE276T01018

  • Incorporation Year

    1988

  • Registered Office

    A-514 Steller Opp Arista Bldg
    Sindhu bhavan Road Bodakdev, Ahmedabad,
    Gujarat-380054

  • Telephone

  • FAX

  • Chairman

    Vrushank Balkrushna Patel

  • Managing Director

    SARANG PATHAK

  • Company Secretary

    Ritu Singh

  • Auditor

    Jain Kedia & Sharma/V V Patel & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-1 Off C.G Road ,Ellisbridge
    Mumbai - Ahmedabad-380006

Adline Chem Lab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Adline Chem Lab 15.79 0.01 0.00 -49.34 0.00
Abbott India 25,593.30 7,217.19 6,929.05 33.68 43.78
Astrazeneca Phar 6,367.35 2,304.07 2,275.58 93.84 27.86
Glaxosmi. Pharma 2,483.55 3,932.76 3,790.20 39.67 58.17
Novartis India 1,693.85 393.10 354.33 42.77 15.94
Cipla 1,380.00 20,102.60 18,979.95 42.06 13.88
Bliss GVS Pharma 648.40 773.53 729.81 60.26 12.51
Amrutanjan Healt 496.85 520.13 502.55 26.61 24.16
Fermenta Biotec. 417.55 474.15 450.25 19.49 18.77
Guj. Themis Bio. 362.50 168.25 165.82 96.93 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77